Table 1.
Comparison and evaluation of the clinical parameters of TANs classification in PDAC patients
| Classification |
TANs negative |
TANs positive |
|||
|---|---|---|---|---|---|
| Variable | Mean | SD | Mean | SD | P Value |
| Age(years) | 61.14 | 6.98 | 62.53 | 3.87 | 0.381 |
| Gender(male/female) | 18/15 | 11/13 | 0.703 | ||
| Platelet(×103/mL) | 210 | 70.2 | 227.5 | 75.51 | 0.673 |
| Lymphocytes(×103/mL) | 1.46 | 0.57 | 1.55 | 0.49 | 0.923 |
| Neutrophil (×103/mL) | 3.44 | 0. 597 | 5.25 | 2.09 | 0.039 |
| AFP(U/mL) | 3.544 | 0. 921 | 4.35 | 1.74 | 0.674 |
| CEA(ng/mL) | 23.9 | 31. 321 | 14.29 | 5. 35 | 0.087 |
| CA125(U/mL) | 21.42 | 16.22 | 23.23 | 9.35 | 0.645 |
| CA199(U/mL) | 379.66 | 622.85 | 512.31 | 821.01 | 0.026 |
| CA242(U/mL) | 71.78 | 112.12 | 141.66 | 155.12 | 0.051 |
| Diameter(cm) | 3.14 | 1.21 | 3.32 | 1.58 | 0.418 |
| PLR | 151.12 | 45.32 | 168.12 | 48.34 | 0.336 |
| NLR | 2.47 | 2.85 | 4.61 | 3.24 | 0.321 |
| AJCC-stage(<ⅡB/≥ⅡB) | 19/15 | 11/13 | 0.595 | ||
| Location (Head/Others) | 30/3 | 23/1 | 0.643 | ||
| Differentiation (well to moderate/others) | 11/22 | 10/14 | 0.585 | ||
Abbreviations: PLR: platelet/lymphocyte ratio; NLR: neutrophil/lymphocyte ratio